Sponsors & Exhibition

industry prospectus

You can find all the info you want about our sponsor and exhibition options in our Industry Prospectus, available for download.

Download Industry Prospectus

Our Educational Partner


Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. In the U.S., Aerie developed and markets Rhopressa® (netarsudil ophthalmic solution) 0.02%, a Rho kinase (ROCK) inhibitor, and the fixed-dose combination Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%. Aerie has established development operations in Europe and Japan and a global manufacturing facility in Ireland. Aerie is expanding its ophthalmic pipeline with two clinical-stage retina programs in the U.S. and exploration of its proprietary library of small-molecule multi-kinase inhibitors.

Visit Aerie online

Aerie is providing an unrestricted education grant to the Advances in Glaucoma Research and Clinical Science Meeting 2019.

Kugler Publications

Kugler Publications

Postal address:
P.O. Box 20538
1001 NM Amsterdam
The Netherlands
Tel: +31 20 68 45 700